Showing 3831-3840 of 6035 results for "".
- Allergan, Mohawk Tribe Ask for Supreme Court Review of Scrutinized Patent Casehttps://modernod.com/news/allergan-mohawk-tribe-ask-for-supreme-court-review-of-scrutinized-patent-case/2476180/Allergan and the St. Regis Mohawk Tribe aim to continue their legal battle in defense of a controversial patent agreement struck a little over a year ago, appealing last week to the Supreme Court to review a federal appeals court decision which had undermined the deal’s main r
- Aerpio Pharmaceuticals Completes Patient Dosing in TIME-2b Study of AKB-9778 in Diabetic Retinopathyhttps://modernod.com/news/aerpio-pharmaceuticals-completes-patient-dosing-in-time-2b-study-of-akb-9778-in-diabetic-retinopathy/2476181/Aerpio Pharmaceuticals announced the completion of patient dosing in the company’s TIME-2b study, a phase 2b clinical trial designed to assess the efficacy and safety of Aerpio’s lead candidate, AKB-9778, for patients with moderate to severe nonproliferative diabetic retinopathy (NPDR). &#
- Acuity Pro Launches Acuity Ten Digital Software and Systemhttps://modernod.com/news/acuity-pro-launches-acuity-ten-digital-software-and-system/2476187/The new Acuity Pro Ten digital visual acuity system is built with future-proofing in mind. Written in a new language, the program looks and feels very familiar with user-interface enhancements designed for ease-of-use, according to a company news release. To keep up with Windows updates and the r
- George A. Williams, MD, Begins Term as 2019 President of the American Academy of Ophthalmologyhttps://modernod.com/news/george-a-williams-md-begins-term-as-2019-president-of-the-american-academy-of-ophthalmology/2476229/George A. Williams, MD, today begins his term as the 123rd president of the American Academy of Ophthalmology. Dr. Williams, a retina specialist, was elected by the Academy’s community of 32,000 ophthalmologists in recognition of his scientific leadership and his deep commitment to advocati
- Unum Poll Finds 40 Percent of Adults Spend 12+ Hours on Devices Each Dayhttps://modernod.com/news/unum-poll-finds-40-percent-of-adults-spend-12-hours-on-devices-each-day/2476235/It’s the time of year when many Americans resolve to eat healthier, get more exercise or save more money. But a new resolution in this digital-crazed culture should be to give your eyes a break from too much screen time. A recent poll by employee benefits company Unum found that 40 percent of U.S
- 2018 Best of Eyetubehttps://modernod.com/news/2018-best-of-eyetube/2476238/Cataract & Refractive Surgery Today (CRST) has compiled the best content of 2018 from Eyetube.net, the leading video resource for ophthalmologists. Below are descriptions of a few of the top videos. To view all of the videos and their descriptions, click
- AMD Monitoring Comes Home: The Promise of Innovative Remote Techhttps://modernod.com/news/amd-monitoring-comes-home-the-promise-of-innovative-remote-tech/2476239/Age-related macular degeneration (AMD) is the leading cause of severe vision loss in older Americans. AMD is a degenerative disease that affects the macula, or the central part of the retina, which has the highest density of photoreceptors, allowing for high-resolution central visual acuity. An e
- Carl Zeiss Meditec Completes Acquisition of IanTECHhttps://modernod.com/news/carl-zeiss-meditec-completes-acquisition-of-iantech/2476242/Carl Zeiss Meditec has officially completed its acquisition of IanTECH, a privately held company focused on technology solutions for micro-interventional cataract surgery headquartered in Reno, Nevada. IanTECH is the maker of the miLOOP Lens Fragmentation Device, which is the first in a li
- First IC-8 Small Aperture IOL Implanted in the United Stateshttps://modernod.com/news/first-ic-8-small-aperture-iol-implanted-in-the-united-states/2476252/AcuFocus announced that the first US patient has been implanted with the IC-8 small aperture IOL as part of its pivotal study of the IC-8 lens in cataract patients. The company recently announced approval for an investigational device exemption (IDE) from the FDA to conduct the study. The
- Criminal Case Against James Mazzo Dismissedhttps://modernod.com/news/criminal-case-against-james-mazzo-dismissed/2476151/After a legal battle that spanned a decade, the insider trading criminal case against ophthalmic executive James Mazzo has come to an end. Late Thursday at the Ronald Reagan Federal Building in Santa Ana, California, federal prosecutors asked Judge Andrew Guilford to dismiss all criminal c